Financial statements are reported in CAD. Prices converted from USD at today's exchange rate. Tranches and alerts stay in USD.
KHRNF — Khiron Life Sciences Corp.
CA$ 0.00
+CA$ 0.00 (+0.00%)
Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe. It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products.
Market Cap
CA$ 3316.12
Forward P/E
N/A
52-Week Range
N/A
KHRNF Price History
Revenue vs. Net Income
CA$ 12.8M
Revenue · FY2021
Annual. Net margin is shown under each year.
Free Cash Flow
-CA$ 22.1M
FCF · FY2021
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-95.9%
ROCE · FY2021
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
4.7x
Assets ÷ liabilities · FY2021
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
13.6%
CapEx · FY2021
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
164.5M
Diluted shares · FY2021
Only one year of share data is available, so no change can be shown yet.
